Cite Filings / MLTX / 0001172661-26-001033

Feed Companies Filings Check

Sign in

SCHEDULE 13G

Statement of Beneficial Ownership

MoonLake Immunotherapeutics Filed 2026-02-17 Acc 0001172661-26-001033

Documents 1

SCHEDULE 13G Statement of Beneficial Ownership , xslSCHEDULE_13G_X01/primary_doc.xml

Around this filing

2026-08-14 SCHEDULE 13G Statement of Beneficial Ownership
2026-02-23 8-K Material agreement · Results of operations · New debt or obligation · Executive or director change · Regulation FD disclosure · Other events
2026-02-17 SCHEDULE 13G Statement of Beneficial Ownership
2025-11-12 SCHEDULE 13G Statement of Beneficial Ownership

Link to a passage

Paste a passage to link it

At least 12 characters, not counting spaces, so the link points to one passage.

External

SEC EDGAR (opens in new tab)

Loading xslSCHEDULE_13G_X01/primary_doc.xml…

Connection lost

Reconnecting…

Cite Filings isn't responding

Reconnecting…